Establishing a yeast-based screening system for discovery of human GLUT5 inhibitors and activators
Abstract Human GLUT5 is a fructose-specific transporter in the glucose transporter family (GLUT, SLC2 gene family). Its substrate-specificity and tissue-specific expression make it a promising target for treatment of diabetes, metabolic syndrome and cancer, but few GLUT5 inhibitors are known. To ide...
Guardado en:
Autores principales: | Joanna Tripp, Christine Essl, Cristina V. Iancu, Eckhard Boles, Jun-yong Choe, Mislav Oreb |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/304ac976992841c9828f6fc9c777528f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of new GLUT2-selective inhibitors through in silico ligand screening and validation in eukaryotic expression systems
por: Sina Schmidl, et al.
Publicado: (2021) -
Crystal structures of non-oxidative decarboxylases reveal a new mechanism of action with a catalytic dyad and structural twists
por: Matthias Zeug, et al.
Publicado: (2021) -
Substrate promiscuity of polyketide synthase enables production of tsetse fly attractants 3-ethylphenol and 3-propylphenol by engineering precursor supply in yeast
por: Julia Hitschler, et al.
Publicado: (2020) -
Peritoneal expression of SGLT-2, GLUT1 and GLUT3 in peritoneal dialysis patients
por: Severin Schricker, et al.
Publicado: (2021) -
High-throughput screening for growth inhibitors using a yeast model of familial paraganglioma.
por: Irina Bancos, et al.
Publicado: (2013)